Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

IGFBP5 anticorps

L’anticorps Lapin Polyclonal anti-IGFBP5 a été validé pour WB et EIA. Il convient pour détecter IGFBP5 dans des échantillons de Humain.
N° du produit ABIN181656

Aperçu rapide pour IGFBP5 anticorps (ABIN181656)

Antigène

Voir toutes IGFBP5 Anticorps
IGFBP5 (Insulin-Like Growth Factor Binding Protein 5 (IGFBP5))

Reactivité

  • 50
  • 32
  • 17
  • 4
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 52
  • 17
  • 3
  • 1
Lapin

Clonalité

  • 54
  • 19
Polyclonal

Conjugué

  • 38
  • 13
  • 8
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp IGFBP5 est non-conjugé

Application

  • 71
  • 28
  • 19
  • 17
  • 14
  • 13
  • 13
  • 5
  • 4
  • 4
  • 3
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Specificité

    This antibody detects Insulin-like Growth Factor Binding Protein 5.

    Purification

    Immunoaffinity Chromatography

    Immunogène

    Highly pure (> 98 %) recombinant human IGF-BP5
  • Indications d'application

    Indirect ELISA: To detect hIGF-BP5 (using 100 μL/well antibody solution) a concentration of0.5-2.0 μg/mL of this antibody is required. In conjunction with compatible secondaryreagents, it allows the detection of at least 0.2-0.4 ng/well of recombinant hIGF-BP5. Sandwich ELISA: To detect hIGF-BP5 (using 100 μL/well antibody solution) a concentrationof 0.5-2.0 μg/mL of this antibody is required. In conjunction with Biotinylated Anti-HumanIGF-BP5 (ABIN181653 or ABIN181654) as a detection antibody, it allows the detection ofat least 0.2-0.4 ng/well of recombinant hIGF-BP5. Western blot: To detect hIGF-BP5 this antibody can be used at a concentration of 0.1-0.2 μg/mL. Used in conjunction with compatible secondary reagents the detection limit forrecombinant hIGF-BP5 is 1.5-3.0 ng/lane, under either reducing or non-reducing conditions.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Restrictions

    For Research Use only
  • Reconstitution

    Centrifuge vial prior to opening. Restore in sterile water to a concentration of 0.1-1.0 mg/mL.

    Buffer

    PBS, pH 7.2

    Conseil sur la manipulation

    Avoid repeated freezing and thawing.

    Stock

    -20 °C

    Stockage commentaire

    Store the lyophilized antibody at -20 °C. Following reconstitution it is stable for two weeks at 2-8 °C. Frozen aliquots are stable for 6 months when stored at -20 °C.

    Date de péremption

    6 months
  • Antigène

    IGFBP5 (Insulin-Like Growth Factor Binding Protein 5 (IGFBP5))

    Autre désignation

    IGFBP5

    Sujet

    IGFBP5 is one of a family of proteins that bind to insulin-like growth factors (IGFs). IGFBP5 is a multifunctional protein which acts not only as a traditional binding protein but also functions as a growth factor independent of IGFs to stimulate bone formation. Currently there are seven named IGF-BPs that form high affinity complexes with both IGFI and IGFII. IGFBP5 is the major IGF-binding protein present in bone tissue and helps potentiate the action of IGFI on smooth muscle cells, fibroblasts or osteoblasts. Data shows that IGFBP5 acts as a growth inhibitor and pro-apoptotic agent in breast cancer cells. IGFBP5 overexpressing mice show an increase in neonatal mortality, reduced female fertility, whole-body growth inhibition and retarded muscle development.Synonyms: IBP-5, IBP5, IGF-binding protein 5, IGFBP-5, Insulin-like growth factor-binding protein 5

    ID gène

    3488

    NCBI Accession

    NP_000590

    UniProt

    P24593

    Pathways

    Signalisation WNT, Carbohydrate Homeostasis, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process, Autophagy, Smooth Muscle Cell Migration, Growth Factor Binding
Vous êtes ici:
Chat with us!